false

Angelique Heckmann, PhD

Angélique Heckmann, PhD is a people‑driven leader who combines scientific expertise and business acumen with a strong foundation in human values. With a background in therapeutic drug development and an MBA‑shaped strategic mindset, she focuses on building meaningful, long‑term relationships with teams, partners, and clients. By bridging science and strategy, she supports informed decision‑making, fosters collaboration, and helps translate innovation into real‑world impact—always guided by a shared purpose: advancing solutions that ultimately improve patients’ lives

• Read: Precision for Medicine Re-approved as a CIR-Eligible R&D Partner Under the French Research Tax Credit Programme

  Precision for Medicine Re-approved as a CIR-Eligible R&D Partner Under the French Research Tax Credit Programme

  Oct 21, ‘26 | 2 min read

  • 

    Angelique Heckmann, PhD

  Discover
• Read: Case Study: Advancing IHC Assays from RUO to Clinical Trials and CDx

  Assays - Oncology

  Case Study: Advancing IHC Assays from RUO to Clinical Trials and CDx

  May 07, ‘26 | 8 min read

  • 

  • Kennon D.

    Angelique H.

  Discover

Loading...

You've reach the end Back to top